Cargando…
Glioblastoma specific antigens, GD2 and CD90, are not involved in cancer stemness
Glioblastoma multiforme (GBM) is the most malignant World Health Organization grade IV brain tumor. GBM patients have a poor prognosis because of its resistance to standard therapies, such as chemotherapy and radiation. Since stem-like cells have been associated with the treatment resistance of GBM,...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Association of Anatomists
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4371180/ https://www.ncbi.nlm.nih.gov/pubmed/25806121 http://dx.doi.org/10.5115/acb.2015.48.1.44 |